MOTIF BIO TO PRESENT ICLAPRIM DATA AT ASM MICROBE 2018

May 8, 2018
Motif Bio plc

NEW YORKMay 08, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that two iclaprim abstracts have been accepted for presentation at the upcoming American Society For Microbiology (ASM) Microbe 2018 meeting to be held in Atlanta, GA, USA, June 7-11, 2018.  The abstracts are now available online on the ASM website.

Press Release available here